Medical biotechnology

Events | Wednesday, March 27, 2024
On March 27, join Medicine by Design in-person for the Building a Biotech Venture Pitch Competition to learn how the...
Network | Project
Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations
The accelerated FDA approval of mirvetuximab soravtansine is a breakthrough for ovarian cancer, particularly for the majority of patients who...
Network | Project
Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs
This study investigated the intricate interplay between drug processing proteins and the inflammatory response triggered by SARS-CoV-2 infection in the...
Network | Project
SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues
This study showed that SARS-CoV-2 infection alters the expression of drug processing proteins like CYP3A4 and P-gp, potentially affecting how...
Network | Researcher Profile
Chukwunonso Nwabufo is the founder of OneDrug and a multiple award-winning pharmacologist with over six years’ experience in drug development...
News | Tuesday, September 12, 2023
Adverse drug reactions are the fourth to sixth most common cause of death globally, according to the National Library of Medicine. Meanwhile,...